History
# Registration date Revision Id
2 2019-02-05, 1397/11/16 79293
1 2018-06-25, 1397/04/04 50392
Changes made to previous revision
This is the first revision

Protocol summary

Study aim
Comprative study of therapeutic effect and Complication of Drugs of Sertraline, Flouxetine and Paroxetine each 12 hours Daily in Premature Ejaculation Patients
Design
This study is a non-randomized, non-placebo-controlled clinical trial and a comparative study on the therapeutic effect of sertraline, Flouxetine and Paroxetine every 12 hours daily in the treatment of premature ejaculation patients. Three hundred sixty patients (each group of one hundred twenty) will be surveyed from July 2018 to July 2020.
Settings and conduct
The location of the study is in the Imam Reza hospital of Tehran affiliated to the Army University of Medical Science. Patients are evaluated by an urologist and, if approved, have an early ejaculation according to the definition of DMS-4 enrollred In this study,after obtaining consent Written.
Participants/Inclusion and exclusion criteria
Inclusion Criteria : Male with Premature Ejaculation؛ Possible at least Once Coitus on Week and Age between 20 to 75 years Exclusion Criteria : Norologic Disorder؛ Psycologic Disorder؛ Age Less than 20 and Over 75 Years؛ Urinary and Genital Infection and History of Pelvic Surgery
Intervention groups
In the first group, it is prescribed 50 mg of sertraline, in the secound group 20 mg flouxetine and in third groug 20 mg paroxetine each 12 hours daily . Finally, the time the ejaculation before treatment (mean time in at least three coitus) and at the end of the fourth and eighth weeks after treatment are accurately measured and recorded by the patient's wife with a stopwatch . Patients are advised to record time from vaginal entrance to ejaculation
Main outcome variables
Time of Ejaculation

General information

Reason for update
Acronym
IRCT registration information
IRCT registration number: IRCT20180401039167N2
Registration date: 2018-06-25, 1397/04/04
Registration timing: prospective

Last update: 2018-06-25, 1397/04/04
Update count: 1
Registration date
2018-06-25, 1397/04/04
Registrant information
Name
Bijan Rezakhaniha
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 21 2264 6431
Email address
reza.bijan1345@ajaums.ac.ir
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2018-07-23, 1397/05/01
Expected recruitment end date
2020-07-22, 1399/05/01
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Comprative Study of Therapeutic Effects of Sertraline, Flouxetine and Paroxetine in Premature Ejaculation
Public title
Study of Therapeutic Effects of Sertraline, Flouxetine and Paroxetine in Premature Ejaculation
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
Male with Premature Ejaculation Possible at least Once Coitus a Week Age between 20 to 75 years
Exclusion criteria:
Norologic Disorder Age Less than 20 and Over 75 Years Psycologic Disorder History of Pelvic Surgery Urinary and Genital Infection
Age
From 20 years old to 75 years old
Gender
Male
Phase
3
Groups that have been masked
No information
Sample size
Target sample size: 360
Randomization (investigator's opinion)
Not randomized
Randomization description
Blinding (investigator's opinion)
Not blinded
Blinding description
Placebo
Not used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Ethics committee of AJA University of Medical Sciences
Street address
Emam Reza Hospital, Sarhang Etemadzadeh Ave, Fatemi Ave
City
Tehran
Province
Tehran
Postal code
IR.26.110791
Approval date
2018-02-25, 1396/12/06
Ethics committee reference number
IR.AJAUMS.REC.1396.112

Health conditions studied

1

Description of health condition studied
Premature Ejaculation
ICD-10 code
F52.4
ICD-10 code description
Premature ejaculation

Primary outcomes

1

Description
Time of Ejaculation ( From Vaginal Entrance to Ejaculation )
Timepoint
The Time of Ejaculation at the Beginning of the Study ( Before the Intervention) and 4 and 8 weeks after the start of Drug
Method of measurement
Measure the time in seconds by the stopwatch by the patient's wife

Secondary outcomes

empty

Intervention groups

1

Description
Intervention group: Sertraline will receive 50 mg every 12 hours from Abidi-Tehran Pharmaceutical Company for 8 weeks.
Category
Treatment - Drugs

2

Description
Intervention group: Flouxetine will receive 20 mg every 12 hours from Abidi-Tehran Pharmaceutical Company for 8 weeks.
Category
Treatment - Drugs

3

Description
Intervention group: Paroxetine will receive 20 mg every 12 hours from Abidi-Tehran Pharmaceutical Company for 8 weeks.
Category
Treatment - Drugs

Recruitment centers

1

Recruitment center
Name of recruitment center
Emam Reza hospital
Full name of responsible person
Bijan Rezakhaniha
Street address
Emam Reza hospital,Sarhang Etemadzadeh Ave, Fatemi St
City
Tehran
Province
Tehran
Postal code
IR.26.110791
Phone
+98 21 8609 5072
Email
reza.bijan@yahoo.com

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Artesh University of Medical Sciences
Full name of responsible person
Dr Arsia Taghva
Street address
Aja University of Medical Sciences, Sarhang Etemadzadeh Ave, Fatemi S
City
Tehran
Province
Tehran
Postal code
IR26.110791
Phone
+98 21 8609 5232
Email
reza.bijan1345@gmail.com
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
No
Title of funding source
Artesh University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

Person responsible for general inquiries

Contact
Name of organization / entity
Artesh University of Medical Sciences
Full name of responsible person
Bijan Rezakhaniha
Position
Associate professor
Latest degree
Specialist
Other areas of specialty/work
Urology
Street address
Emam Reza Hospital, Sarhang Etemadzadeh st, Fatemi st
City
Tehran
Province
Tehran
Postal code
IR26.110791
Phone
+98 21 8609 5072
Email
reza.bijan@yahoo.com

Person responsible for scientific inquiries

Contact
Name of organization / entity
Artesh University of Medical Sciences
Full name of responsible person
Bijan Rezakhaniha
Position
Associate professor
Latest degree
Specialist
Other areas of specialty/work
Urology
Street address
Emam Reza Hospital, Sarhang Etemadzadeh st, Fatemi st
City
Tehran
Province
Tehran
Postal code
IR26.110791
Phone
+98 21 8609 5072
Email
reza.bijan@yahoo.com

Person responsible for updating data

Contact
Name of organization / entity
Artesh University of Medical Sciences
Full name of responsible person
Bijan Rezakhaniha
Position
Associate professor
Latest degree
Specialist
Other areas of specialty/work
Urology
Street address
Emam Reza Hospital, Sarhang Etemadzadeh st, Fatemi st
City
Tehran
Province
Tehran
Postal code
IR26.110791
Phone
+98 21 8609 5072
Email
reza.bijan@yahoo.com

Sharing plan

Deidentified Individual Participant Data Set (IPD)
Undecided - It is not yet known if there will be a plan to make this available
Study Protocol
Undecided - It is not yet known if there will be a plan to make this available
Statistical Analysis Plan
Undecided - It is not yet known if there will be a plan to make this available
Informed Consent Form
Undecided - It is not yet known if there will be a plan to make this available
Clinical Study Report
Undecided - It is not yet known if there will be a plan to make this available
Analytic Code
Undecided - It is not yet known if there will be a plan to make this available
Data Dictionary
Undecided - It is not yet known if there will be a plan to make this available
Loading...